Pial arterioles on the surface of the mouse brain were observed in vivo under a chamber with a glass window. When placed under the window, calcium ionophore, acetylcholine, and previously acidified sodium nitrite each dilated the arterioles. If the cyclooxygenase inhibitors indomethacin or acetylsalicylic acid were first placed in the chamber, subsequent dilation of the arterioles by calcium ionophore was reduced to essentially zero. Similar blockade of cyclooxygenase failed to significantly reduce dilation by acetylcholine or sodium nitrite. We have previously shown that dilations by calcium ionophore and acetylcholine were endothelium dependent. Our present experiments show that the endothelium-dependent mechanism for dilation by calcium ionophore is cyclooxygenase dependent, while that for acetylcholine is not. This implies that, in pial arterioles, the endothelium-derived relaxing factor for acetylcholine differs from that for calcium ionophore. This agrees with data from other microvascular beds. I n mouse and cat cerebral microvessels on the surface of the brain (pial arterioles), we have demonstrated endothelium-dependent relaxation and constriction in vivo.
In conductance arteries, there is evidence that the endothelium-derived relaxing factor (EDRF) is the same for all three dilators. 6 Moreover, this EDRF (sometimes called classical EDRF) is not cyclooxygenase dependent and hence relaxation by the three dilators is not blocked by cyclooxygenase inhibitors such as indomethacin. 1 -4 However, in large vessels, prostacyclin (a product of cyclooxygenase activity) is also recognized as an EDRF, albeit not the classical EDRF. Moreover, there may be other EDRFs released from other large vessels.
In the microcirculation, where major control of vascular resistance occurs, there also appears to be a variety of endothelium-dependent relaxing mechanisms. For example, in arterioles of rat cremaster muscle ACh causes dilation via an endotheliumdependent mechanism 7 that is independent of cyclooxygenase, 8 ' 9 whereas endothelium-dependent dilation caused by calcium ionophore is totally dependent upon cyclooxygenase. 8 ' 9 In pial arterioles of cats or mice, the EDRF for bradykinin is a free radical, the production of which is prevented by hydroxyl scavengers, while the EDRF for ACh is (at least in cats) aided by radical scavenging. The latter data show that in pial arterioles the EDRF for ACh is different from that for bradykinin, and this conclusion is also supported by other studies. 13 We tested the hypothesis that in mouse pial arterioles the EDRF for dilation by ACh is also different from that for calcium ionophore. We hypothesized that calcium ionophore will be cyclooxygenase dependent; hence, its EDRF will be unlike classical EDRF but will be similar to that for calcium ionophore in rat cremaster microvessels. 8 ' 9 Distinctions of this sort are important if we are to understand, and ultimately control, endotheliummediated relaxation in resistance vessels.
Materials and Methods Our data was obtained from 43 male mice (Harlan Farms, Indianapolis, Indiana; ICR strain) weighing 30-40 g and anesthetized with urethane. A trache-ostomy and craniotomy were performed and the dura was stripped in each mouse, revealing the transparent arachnoid with the underlying pial vessels in the subarachnoid space.
14 A closed cranial chamber approximately 0.15 ml in volume was placed over this site. The wall of the chamber was cut from the barrel of a 3-ml plastic syringe and glued to the bony margins of the craniotomy site with dental cement (Duralon, Premier Dental Products, Norristown, Pennsylvania). A posterior inflow port and an anterior outflow port were made of plastic tubing into which a 19-gauge needle fit snugly. The ports were cemented into grooves on the top of the chamber wall. A cover glass was then cemented over the entire chamber. Mock cerebrospinal fluid (CSF) (Elliott's solution 15 ) could then be injected under the window and flushed out with fresh mock CSF or with mock CSF containing a drug.
The chamber was filled with mock CSF at 37° C, and the mouse was placed on a mattress at 37° C for temperature equilibration for 30 minutes. The pH under the window was controlled by adjusting the CO 2 in the mock CSF. The mean±SEM pH was 7.35 ±0.02 as determined by withdrawing mock CSF from the chamber after 10 minutes. The field was observed with a Leitz Ultropak microscope (Rockleigh, New Jersey) and a television camera and monitor, and the initial diameter of a single pial arteriole was monitored by an image shearing technique. 16 Arterioles for study were arbitrarily chosen from those with initial diameters between 28 and 40 /xm. Mock CSF under the window was then replaced with mock CSF containing the dilator, diluent, cyclooxygenase inhibitor, or dilator plus cyclooxygenase inhibitor to be tested, all at 37° C. Diameter was monitored until the maximal response was established (5-10 minutes). The increased diameter was expressed as a percent of the baseline diameter determined immediately before the application of each drug or drug combination. The chamber was then washed out with mock CSF, and (where called for by the protocol) a new drug or drug combination was applied in fresh mock CSF. When multiple tests of a vasodilator were made in a single mouse, 15 minutes elapsed between applications of the dilator. The pretreatment responses were compared with posttreatment responses using the Mann-Whitney test. 17 A nonparametric test was used because the distribution of data expressed as percentages is not normal.
The drugs used were calcium ionophore A-23187, dimethylsulfoxide (DMSO), ACh Cl, NaNo 2 (Sigma Chemical Co., St. Louis, Missouri), indomethacin (Vanguard Laboratories), and acetylsalicylic acid (ASA, Sigma). Stock solutions of calcium ionophore were made in DMSO; dilutions of 1 /A/ml mock CSF gave a final concentration of 10" 5 M. Stock solutions of ACh were made daily in deionized water; dilutions of 16 /j,l/ml mock CSF gave a final concentration of 80 jig/ml (4xlO~4 M). NaNO 2 was dissolved in deionized water to give a concentration of 10"' M; the pH was adjusted to 2 with HC1, generating the powerful endotheliumindependent dilator nitric oxide, which was trapped by freezing the solution 18 to preserve it overnight. Fresh stock solution was made every 2 days. Nitric oxide was released by diluting 10 ju-1 of the fresh or thawed stock solution in 1 ml warmed mock CSF to give a final concentration of 10" 3 M, which was immediately placed under the cranial window. Stock solutions of indomethacin and ASA were made daily in phosphate buffer (pH 8), and dilutions in mock CSF of 4 /xl/ml and 20 /A/ml gave final concentrations of 6xlO" 5 M and 6xlO~4 M, respectively. The final pH of each drug-containing solution was always controlled by adjusting CO 2 in the mock CSF. The mean±SEM pH of all drugcontaining solutions placed under the window was 7.32±0.01.
At the end of each experiment, 100 /xl blood from the mouse's carotid artery was taken for measurement of CO 2 , O 2 , and pH. This attested to the condition of the mice. The values were similar from study to study and the means±SDs were Paco 2 , 31 ±4 mm Hg; Pao 2 , 120±ll mm Hg; and pH, 7.38±0.04.
Results
We tested the effect of cyclooxygenase blockers on calcium ionophore in 21 mice. In 10 mice, calcium ionophore produced a 7±1% dilation. Fifteen minutes later, the diluent (mock CSF with 0.1% DMSO) was tested and had no effect (diameter 99±1% of baseline). After washout of the diluent, indomethacin was applied for 7 minutes and calcium ionophore was tested in its presence. Calcium ionophore now had no effect (diameter 101 ±1% of baseline, p< 0.01 compared with before indomethacin; Table 1 ). Expressed as a percent of the response before indomethacin, the response after indomethacin was only 16%, with vessels of eight mice failing to respond at all. Fifteen minutes later, to see whether the arterioles were still able to dilate, NaNO 2 was tested; every arteriole relaxed (Table 1) .
Similar results were observed in a separate test with ASA in 11 additional mice. Calcium ionophore produced a 7±2% dilation. The diluent had no effect (diameter 99±1% of baseline). After washout of the diluent, the vessels were exposed to ASA for 7 minutes and calcium ionophore was tested in the presence of ASA. Calcium ionophore now had no effect (diameter 101±l% of baseline, p<0.01 compared with before ASA; Table 1 ). Expressed as a percent of the response before ASA, the response after ASA was only 16%, with vessels of seven mice failing to respond at all. Fifteen minutes later, NaNO 2 dilated the same arterioles (Table 1) . Moreover, each of the four arterioles that displayed some residual capacity to relax in response to calcium ionophore after ASA dilated further to NaNO 2 . We also tested the selectivity of the apparent indomethacin effect. ACh, another endotheliumdependent dilator, dilated arterioles in 10 mice by 11 ±2%. The diluent again had no effect (diameter 100±l% of baseline). The diluent was washed out, and following 7 minutes' exposure to indomethacin ACh in its presence dilated the vessels 7±1% (/>>0.10, not different from before indomethacin; Table 1 ). This response was 68% of that to ACh before indomethacin, and vessels in every mouse responded. Moreover, in three of the six mice in which the postindomethacin response was less than the preindomethacin response, the entire reduction in response could be accounted for by encroachment of a rising baseline on the maximal diameter, shown by tests of responsivity using NaNO 2 . In these three mice, the postindomethacin response to ACh and the response to NaNO 2 were the same, indicating that the postindomethacin response to ACh was all that the vessels were capable of producing.
We next tested the effect of indomethacin on the response to the endothelium-independent dilator NaNO 2 in a separate study of 11 additional mice. Before indomethacin, NaNO 2 dilated the vessels 15±2%; after indomethacin, NaNO 2 dilated the vessels 8±2%, a response that was 59% of that before indomethacin (p>0.10, not different from that before indomethacin; Table 1 ). Most of the reduction in response was due to two mice, the arterioles of which had apparently relaxed maximally during the experiment, so that no further diameter increase was possible. In these two mice, diameter spontaneously increased to the level produced by the first application of NaN0 2 after recovery; the arterioles failed to dilate further when exposed to NaNO 2 after indomethacin treatment.
To rule out any effect of the phosphate buffer and as a further test of the effect of time, we used 11 additional mice. The first exposure to calcium ionophore produced a 6±1% dilation ( Table 1) . Application of the diluent had no effect (diameter 101 ±1% of baseline). Mock CSF containing the phosphate buffer was then placed under the window for 7 minutes, and calcium ionophore was tested in its presence. Six of the 11 vessels still responded, the increase in diameter for all 11 vessels being 3±1% of baseline (p>0.10, not different from before buffer; Table 1 ). The average response of all responses to calcium ionophore after buffer was 55% of that before buffer.
Discussion
Our important findings are that the cyclooxygenase inhibitors indomethacin and ASA block the dilation of pial arterioles that would otherwise be produced by calcium ionophore and that in contrast, the dilations produced by another endotheliumdependent dilator (ACh) and by NaNO 2 (an endothelium-independent dilator) were not blocked. We have previously shown that both ACh and calcium ionophore are endothelium-dependent dilators 1 -3 of pial arterioles. The fact that one dilator is also cyclooxygenase dependent while the other is not suggests that two different EDRFs are involved. This conclusion is identical to that drawn by others from investigations of the cremaster microcirculation. 8 ' 9 Thus, the microvascular beds in brain and cremaster appear to differ from conductance vessels and cultured endothelial cells, where ACh and calcium ionophore both produce an EDRF even when cyclooxygenase is blocked. 4 -6 Selectivity of the effect of indomethacin was shown by the fact that it did not interfere with the response to ACh or NaNO 2 . The phosphate buffer used with indomethacin and ASA had no effect on the response to calcium ionophore.
The baseline diameter rose early during the course of most experiments; the cause of this rise could not be determined. It was the same (2-3 /xm) in all experiments whether or not a subsequent inhibitory effect of cyclooxygenase blockade was demonstrated. This rise in baseline diameter preceded application of indomethacin or ASA and created the possibility that subsequent responses would be blunted, not because of cyclooxygenase inhibition but because the dilating capacity had already been encroached upon by the rising baseline diameter. It was even possible that maximal diameter had already been reached. In the experiments with calcium ionophore, this latter possibility was eliminated by testing each arteriole with NaNO 2 at the end of each experiment. Following cyclooxygenase inhibition, most arterioles failed to respond at all to calcium ionophore, yet all responded to NaNO 2 . Moreover, those arterioles with a response only partially blunted by cyclooxygenase inhibition were still capable of even greater dilation (as shown by their response to NaNO 2 ).
As an arithmetic consequence of rising baseline diameters, dilations expressed as a percent of the baseline decline. The 2-3 fim rise in baseline diameter seen in each experiment contributed to this phenomenon and encroached on any remaining dilating capacity. However, these phenomena by themselves failed to significantly inhibit dilation. They may have accounted for the nonsignificant reductions in the dilating responses to ACh or NaNO 2 following cyclooxygenase blockade and for the nonsignificant effect of phosphate buffer.
A significant effect was observed only in tests of calcium ionophore with cyclooxygenase blockade. Since the rise in baseline diameter was no greater in these than in the other experiments, it could not have accounted for the significant inhibition of calcium ionophore's action. The real effect of cyclooxygenase blockade on the action of calcium ionophore was manifest not merely by statistical significance and the very low probability value (<0.01) but also by the total absence of response in vessels of 15 of the 21 mice treated with calcium ionophore in the presence of indomethacin or ASA. This contrasts with the experiments using indomethacin and ACh, indomethacin and NaNO 2 , or phosphate buffer and calcium ionophore, where vessels in only five of 32 mice failed to respond to the dilator after treatment.
The phenomenon of endothelium-dependent relaxation is important, particularly since it exists in the resistance vessels, or the microcirculation.
1 -3 ' 7 The identity of EDRFs is a subject of intense investigation and some controversy. 6 -19 -23 Where calcium ionophore produces the same EDRF as ACh and other agents of physiologic or pathophysiologic interest, calcium ionophore may be used as a tool to study the nature, production, and release of that particular EDRF. Apparently, in the microcirculation calcium ionophore causes release of an EDRF different from that released by ACh. The latter is of potential physiologic and pathophysiologic importance in the brain microcirculation because ACh can reach microvascular endothelium from perivascular nerves and from damaged brain parenchyma, where it may be released in large amounts. In brain microvessels, the EDRF for ACh has already been shown to resemble classical EDRF in that it is inhibited by methylene blue and is augmented by radical scavengers.
6 -11 -13 - 24 To these similarities we add cyclooxygenase independence. Since calcium ionophore appears to release a different EDRF, its use as a dilator of brain microvessels cannot provide useful information concerning the EDRF released by ACh. However, the EDRF for calcium ionophore in brain microvessels may be identical to that for bradykinin, another agent of potential pathophysiologic importance. 25 The EDRF for bradykinin is also cyclooxygenase dependent. 25 The diameter changes we observed averaged 7-11% for calcium ionophore and ACh. Since the relation of flow to diameter is a third-or fourthpower exponential and since the arterioles involved are resistance vessels, the diameter changes may be paralleled by significant alterations in blood flow. However, the magnitude of these effects is not really the focus of this paper. Their magnitude will be a function of many factors including initial tone and the balance of simultaneously acting dilating and constricting vectors. EDRFs are one group of dilating vectors. Our data indicate that in this microvascular bed, the EDRF for ACh and that for calcium ionophore are different.
